𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Torasemide in the treatment of patients with cirrhosis and ascites

✍ Scribed by Paolo Gentilini; Giacomo Laffi; Giorgio La Villa; Vinicio Carloni; Marco Foschi; Roberto Giulio Romanelli; Fabio Marra

Publisher
Springer US
Year
1993
Tongue
English
Weight
493 KB
Volume
7
Category
Article
ISSN
0920-3206

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Torasemide in the treatment of patients
Torasemide in the treatment of patients with cirrhosis and ascites
✍ Paolo Gentilini; Giacomo Laffi; Giorgio La Villa; Vinicio Carloni; Marco Foschi; πŸ“‚ Article πŸ“… 1993 πŸ› Springer US 🌐 English βš– 493 KB

The effects of torasemide (20 mg/day) and furosemide (50 mg/day), each given over 4 days, were compared in a randomized and crossover study carried out in seven patients with cirrhosis and tense ascites. Patients also received a low-sodium (40 mmol/day) diet and the aldosterone antagonist, potassium

Beta-blockers in patients with cirrhosis
Beta-blockers in patients with cirrhosis and refractory ascites
✍ Albillos AgustΓ­n; Zamora Javier πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 296 KB πŸ‘ 2 views

We read with interest the reviews by Ghouri et al. 1 and Martinez et al. 2 Ghouri et al. analyzed the association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular disease (CVD) and concluded that although a diagnosis of NAFLD should prompt diabetes screening, it is insufficient for co